I think we can all deduce that Alan is a crusty old Kronie with poor to limited grasp on bio-tech. For a professional finance journalist, of his experience, one might expect more. BUT Alan was built a career on casting opinion where his opinion is unjust. Anyone that feels vindicated by Alan Kohler is an unhinged loner! Alan’s research was akin to that of a West Australian stockbroker. Poor
Sharewise Presentation 22/7/24, page-122
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $70.04M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 20.0¢ | $2.253K | 11.26K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 267958 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 164157 | 5 |
View Market Depth
| Last trade - 10.06am 07/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |